These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 32249490)

  • 1. Systematic characterization of non-coding RNAs in triple-negative breast cancer.
    Mei J; Hao L; Wang H; Xu R; Liu Y; Zhu Y; Liu C
    Cell Prolif; 2020 May; 53(5):e12801. PubMed ID: 32249490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress of non-coding RNAs in triple-negative breast cancer.
    Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY
    Life Sci; 2021 May; 272():119238. PubMed ID: 33600860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
    Paul U; Banerjee S
    Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNAs (lncRNAs) in triple negative breast cancer.
    Wang Q; Gao S; Li H; Lv M; Lu C
    J Cell Physiol; 2017 Dec; 232(12):3226-3233. PubMed ID: 28138992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
    Xia M; Zu X; Chen Z; Wen G; Zhong J
    Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs, another side of immune regulation during triple-negative breast cancer.
    Alghazali MW; Al-Hetty HRAK; Ali ZMM; Saleh MM; Suleiman AA; Jalil AT
    Pathol Res Pract; 2022 Nov; 239():154132. PubMed ID: 36183439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers.
    Kong X; Liu W; Kong Y
    J Cell Mol Med; 2018 Jan; 22(1):390-394. PubMed ID: 28941134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia.
    Liu Y; Cheng Z; Pang Y; Cui L; Qian T; Quan L; Zhao H; Shi J; Ke X; Fu L
    J Hematol Oncol; 2019 May; 12(1):51. PubMed ID: 31126316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.
    Lyu L; Zhang S; Deng Y; Wang M; Deng X; Yang S; Wu Y; Dai Z
    J Hematol Oncol; 2021 Mar; 14(1):41. PubMed ID: 33676555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
    Feng Q; Zhang H; Yao D; Chen WD; Wang YD
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of long non‑coding RNA‑mediated transcriptional dysregulation triplets reveals global patterns and prognostic biomarkers for ER+/PR+, HER2‑ and triple negative breast cancer.
    Du Z; Gao W; Sun J; Li Y; Sun Y; Chen T; Ge S; Guo W
    Int J Mol Med; 2019 Sep; 44(3):1015-1025. PubMed ID: 31257479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic characterization and biological functions of non-coding RNAs in glioblastoma.
    Dai L; Liang W; Shi Z; Li X; Zhou S; Hu W; Yang Z; Wang X
    Cell Prolif; 2023 Mar; 56(3):e13375. PubMed ID: 36457281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of long non-coding RNAs and circular RNAs in bone regeneration: Modulating miRNAs function.
    Ping J; Li L; Dong Y; Wu X; Huang X; Sun B; Zeng B; Xu F; Liang W
    J Tissue Eng Regen Med; 2022 Mar; 16(3):227-243. PubMed ID: 34958714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs-mediated cell fate in triple negative breast cancers.
    Sui X; Wang X; Han W; Li D; Xu Y; Lou F; Zhou J; Gu X; Zhu J; Zhang C; Pan H
    Cancer Lett; 2015 May; 361(1):8-12. PubMed ID: 25748387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
    Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
    Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long non-coding RNA landscape in triple-negative breast cancer.
    Zhang W; Guan X; Tang J
    Cell Prolif; 2021 Feb; 54(2):e12966. PubMed ID: 33314471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.